References
- World Health Organization. Influenza (Seasonal) fact sheet. 2018 [accessed 2023 Jan 10]. https://www.who.int/news-room/fact-sheets/detail/influenza-/seasonal/.
- Uyeki TM. High-risk groups for influenza complications. JAMA. 2020;324(22):2334. doi:10.1001/jama.2020.21869.
- Burls A, Jordan R, Barton P, Olowokure B, Wake B, Albon E, Hawker J. Vaccinating healthcare workers against influenza to protect the vulnerable—is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine. 2006;24(19):4212–6. doi:10.1016/j.vaccine.2005.12.043.
- Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG, et al. Influenza. Nat Rev Dis Primers. 2018;4(1):3. doi:10.1038/s41572-018-0002-y.
- Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016;16(8):942–51. doi:10.1016/S1473-3099(16)00129-8.
- Wu NC, Zost SJ, Thompson AJ, Oyen D, Nycholat CM, McBride R, Paulson JC, Hensley SE, Wilson IA. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. 2017;13(10):e1006682. doi:10.1371/journal.ppat.1006682.
- Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci USA. 2017;114(47):12578–83. doi:10.1073/pnas.1712377114.
- Rajaram S, Boikos C, Gelone DK, Gandhi A. 2020. Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing. Ther Adv Vaccines Immunother. 8:2515135520908121. doi:10.1177/2515135520908121.
- Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, Kniss K, Burns E, Rowe T, Foust A, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic — United States, 2020–2021. Morb Mortal Wkly Rep. 2021;70(29):1013–19. doi:10.15585/mmwr.mm7029a1.
- Ashraf M, Rajaram S, English PM. How the COVID-19 pandemic will shape influenza public health initiatives: the UK experience. Hum Vaccines Immunother. 2022;18(5):2056399. doi:10.1080/21645515.2022.2056399.
- Department of Health and Social Care. National flu immunisation programme 2022 to 2023 letter. 2022 [accessed 2022 Oct 24]. https://www.gov.uk/government/publications/national-flu-immunisation-programme-plan/national-flu-immunisation-programme-2022-to-2023-letter.
- Kohli MA, Maschio M, Mould-Quevedo JF, Ashraf M, Drummond MF, Weinstein MC. The cost-effectiveness of expanding vaccination with a cell-based influenza vaccine to low risk adults aged 50 to 64 years in the United Kingdom. Vaccines (Basel). 2021;9(6):598. doi:10.3390/vaccines9060598.
- Nguyen VH, Mould-Quevedo JF. Estimating the impact of influenza vaccination on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the US. Vaccines (Basel). 2022;10(11):1908. doi:10.3390/vaccines10111908.
- Baguelin M, Jit M, Miller E, Edmunds WJ. Health and economic impact of the seasonal influenza vaccination programme in England. Vaccine. 2012;30(23):3459–62. doi:10.1016/j.vaccine.2012.03.019.
- British Medical Association. NHS hospital beds data analysis. 2022 [accessed 2022 Nov 15]. https://www.bma.org.uk/advice-and-support/nhs-delivery-and-workforce/pressures/nhs-hospital-beds-data-analysis.
- Fingar KR, Liang L, Stocks C. Inpatient hospital stays and emergency department visits involving influenza, 2006–2016. HCUP Statistical Brief #253. Rockville, MD: Agency for Healthcare Research and Quality; 2019. https://us.ahrq.gov/reports/statbriefs/sb253-Influenza-Hospitalizations-ED-Visits-2006-2016.pdf.
- Lina B, Georges A, Burtseva E, Nunes MC, Andrew MK, McNeil SA, Ruiz-Palacios GM, Feng L, Kyncl J, Vanhems P, et al. Complicated hospitalization due to influenza: results from the Global Hospital Influenza Network for the 2017–2018 season. BMC Infect Dis. 2020;20(1):465. doi:10.1186/s12879-020-05167-4.
- Our World in Data. Coronavirus (COVID-19) hospitalizations. 2022 [accessed 2022 Oct 4]. https://ourworldindata.org/covid-hospitalizations.
- Public Health England. Surveillance of influenza and other respiratory viruses in the UK - winter 2019 to 2020. [accessed 2022 Oct 4]. https://webarchive.nationalarchives.gov.uk/ukgwa/20220401215804mp_/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/895233/Surveillance_Influenza_and_other_respiratory_viruses_in_the_UK_2019_to_2020_FINAL.pdf.
- Department of Health and Social Care. Guidance. Appendix A: groups included in the national influenza immunisation programme. Updated 2022 Jul 22 [accessed 2023 Feb 14]. https://www.gov.uk/government/publications/national-flu-immunisation-programme-plan/appendix-a-groups-included-in-the-national-influenza-immunisation-programme.
- National Institute for Health and Care Excellence. BNF Influenza vaccine medicinal forms. 2022 [accessed 2022 Oct 4]. http://bnf.nice.org.uk/drugs/influenza-vaccine/medicinal-forms/#solution-for-injection.
- Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics. 2008;26(11):911–24. doi:10.2165/00019053-200826110-00004.
- Office for National Statistics. Labour market overview, UK. 2022 Nov [accessed 2022 Dec 1]. https://www.ons.gov.uk/employmentandlabourmarket/peopleinwork/employmentandemployeetypes/bulletins/uklabourmarket/latest.
- Baguelin M, Camacho A, Flasche S, Edmunds WJ. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study. BMC Med. 2015;13(1):236. doi:10.1186/s12916-015-0452-y.
- van Hoek AJ, Underwood A, Jit M, Miller E, Edmunds WJ, van Hoek AJ. The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study. PLoS One. 2011;6(3):e17030. doi:10.1371/journal.pone.0017030.
- Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998;316(7133):736–41. doi:10.1136/bmj.316.7133.736.
- Turner DA, Wailoo AJ, Cooper NJ, Sutton AJ, Abrams KR, Nicholson KG. The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age. Vaccine. 2006;24(7):1035–43. doi:10.1016/j.vaccine.2004.12.033.
- Australian Government Department of Health. Australian Influenza Surveillance Report no. 14. 2022 [accessed 2022 Nov 18]. https://www.health.gov.au/resources/collections/australian-influenza-surveillance-reports-2022.
- Eichner M, Schwehm M, Eichner L, Gerlier L. Direct and indirect effects of influenza vaccination. BMC Infect Dis. 2017;17(1):308. doi:10.1186/s12879-017-2399-4.